Reactive oxygen species (ROS) as pleiotropic physiological signalling agents

被引:0
|
作者
Helmut Sies
Dean P. Jones
机构
[1] Heinrich Heine University Düsseldorf,Institute for Biochemistry and Molecular Biology I
[2] Heinrich Heine University Düsseldorf,Leibniz Research Institute for Environmental Medicine
[3] Emory University,Department of Medicine
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
‘Reactive oxygen species’ (ROS) is an umbrella term for an array of derivatives of molecular oxygen that occur as a normal attribute of aerobic life. Elevated formation of the different ROS leads to molecular damage, denoted as ‘oxidative distress’. Here we focus on ROS at physiological levels and their central role in redox signalling via different post-translational modifications, denoted as ‘oxidative eustress’. Two species, hydrogen peroxide (H2O2) and the superoxide anion radical (O2·−), are key redox signalling agents generated under the control of growth factors and cytokines by more than 40 enzymes, prominently including NADPH oxidases and the mitochondrial electron transport chain. At the low physiological levels in the nanomolar range, H2O2 is the major agent signalling through specific protein targets, which engage in metabolic regulation and stress responses to support cellular adaptation to a changing environment and stress. In addition, several other reactive species are involved in redox signalling, for instance nitric oxide, hydrogen sulfide and oxidized lipids. Recent methodological advances permit the assessment of molecular interactions of specific ROS molecules with specific targets in redox signalling pathways. Accordingly, major advances have occurred in understanding the role of these oxidants in physiology and disease, including the nervous, cardiovascular and immune systems, skeletal muscle and metabolic regulation as well as ageing and cancer. In the past, unspecific elimination of ROS by use of low molecular mass antioxidant compounds was not successful in counteracting disease initiation and progression in clinical trials. However, controlling specific ROS-mediated signalling pathways by selective targeting offers a perspective for a future of more refined redox medicine. This includes enzymatic defence systems such as those controlled by the stress-response transcription factors NRF2 and nuclear factor-κB, the role of trace elements such as selenium, the use of redox drugs and the modulation of environmental factors collectively known as the exposome (for example, nutrition, lifestyle and irradiation).
引用
收藏
页码:363 / 383
页数:20
相关论文
共 50 条
  • [1] Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
    Sies, Helmut
    Jones, Dean P.
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2020, 21 (07) : 363 - 383
  • [2] Reactive oxygen species (ROS) and redox buffers as an interface between stress sensing, signalling and physiological responses in Daphnia magna
    Becker, D.
    Brinkmann, B.
    Budeus, B.
    Schnell, U.
    Zumbraegel, S.
    Zeis, B.
    Paul, R. J.
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY, 2009, 154 (01): : S3 - S3
  • [3] The integration of reactive oxygen species (ROS) and calcium signalling in abiotic stress responses
    Ravi, Barkha
    Foyer, Christine H.
    Pandey, Girdhar K.
    PLANT CELL AND ENVIRONMENT, 2023, 46 (07): : 1985 - 2006
  • [4] The pleiotropic functions of reactive oxygen species in cancer
    Wu, Katherine
    El Zowalaty, Ahmed Ezat
    Sayin, Volkan I.
    Papagiannakopoulos, Thales
    NATURE CANCER, 2024, 5 (03) : 384 - 399
  • [5] In vivo efficacy study of reactive oxygen species (ROS) inducible anticancer agents
    Zaman, Muhammad Asad Uz
    Fan, Heli
    Campbell, Anahit
    Peng, Xiaohua
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [6] REACTIVE OXYGEN SPECIES (ROS) AND INFLAMMATION
    MULLERPEDDINGHAUS, R
    DEUTSCHE TIERARZTLICHE WOCHENSCHRIFT, 1989, 96 (04): : 210 - 212
  • [7] Dissecting the pleiotropic roles of reactive oxygen species (ROS) in lung cancer: From carcinogenesis toward therapy
    Hou, Ying
    Wang, Heng
    Wu, Jiarui
    Guo, Hongwei
    Chen, Xiuping
    MEDICINAL RESEARCH REVIEWS, 2024, 44 (04) : 1566 - 1595
  • [8] Reactive oxygen species (ROS) in multistage carcinogenesis
    Panayiotidis, Mihalis
    CANCER LETTERS, 2008, 266 (01) : 3 - 5
  • [9] POTENTIAL EFFECTS OF REACTIVE OXYGEN SPECIES (ROS)
    Amir, R.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S277 - S277
  • [10] Reactive Oxygen Species (ROS)-Based Nanomedicine
    Yang, Bowen
    Chen, Yu
    Shi, Jianlin
    CHEMICAL REVIEWS, 2019, 119 (08) : 4881 - 4985